Division of Nephrology, University of California I
101 City Drive South, City Tower, Suite 400-ZOT;40
Orange, CA California 92868-3217
United States
University of California, Irvine
ovarian cancer, surgery, intraoperative molecular imaging, debulking
uterine clear cell cancer, adjuvant treatment, high-risk endometrial cancer, prognosis